Icatibant Acetate Related Compounds & Impurities

Icatibant Acetate is a selective bradykinin B2 receptor antagonist used for acute attacks of hereditary angioedema.

Simson Pharma Limited along with its subsidiary offices Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) is a trusted manufacturer and supplier of high-quality pharmaceutical reference standards, offering a comprehensive portfolio of Icatibant Acetate reference standards, pharmacopeial and non-pharmacopeial Icatibant Acetate impurities, related compounds, related substances, metabolites, stable isotope-labelled compounds, deuterium labelled compounds and nitrosamine (N-NO) reference standards.

These materials support pharmaceutical research and development, product development, ANDA and DMF submissions, quality control (QC), analytical method development and validation, stability studies, impurity identification, and genotoxic impurity assessment.

Our Icatibant Acetate-related reference standards are thoroughly characterized using advanced analytical techniques and are supplied with comprehensive Certificates of Analysis (COA) and supporting analytical data from our USFDA certified, ISO 17025 and ISO 17034 accredited Lab, to meet global regulatory expectations. EP and USP traceable reference standards can also be provided upon request, subject to availability. Simson is also a provider of EP and USP traceable standards. To ensure consistent quality and reliability, our reference standards are periodically re-tested according to established quality management procedures.

Pharmaceutical Reference Standards / Impurity Standards

Icatibant Acetate
D-Thi(6)-Icatibant
Des[Pro(3)-Hyp(4)]-Icatibant
D-Ser (7) Icatibant
Des[Pro(3)- Hyp(4)]-Icatibant Epimer
D-Arg(10)-Icatibant
D-Pro(3)-Icatibant
N-terminal Acetylated Icatibant [Ac-D-Arg(1)-ICA]
D-Arg-Arg-Pro-Hyp-Gly-Thi-D-Ser-D-Tic-Oic-Arg-OH
Arg-Pro-Hyp-Gly-Thi-D-Ser-D-Tic-Oic-Arg-OH
AC-D-Arg-Arg-Pro-Hyp-Gly-Thi-Ser-D-Tic-Oic-Arg-OH
Icatibant Impurity 6 Dihydrochloride
Icatibant Acetate Impurity A
Icatibant Acetate Impurity B
Icatibant Acetate Impurity C
Icatibant Tetra-Acetate
Icatibant Impurity 7 Tri-Trifluoroacetate
Icatibant[1-5]-ITBT
Icatibant [8-10]-ITBT
Icatibant Peptide Fragment [1-7]
Icatibant Peptide Fragment [9-10]
Icatibant Peptide Fragment [1-6]
Icatibant Peptide Fragment [Des-Oic9]
Icatibant Peptide Fragment [Des-D-Tic8]
Icatibant Peptide Fragment [D-Oic9]
Icatibant Peptide Fragment [7 -10]
Icatibant Peptide Fragment [D-Thi6]
Icatibant Peptide Fragment [Des-Pro3]
Icatibant Peptide Fragment [D-Cis-Hyp4]
Icatibant Peptide Fragment [L-Cis-Hyp4]
Icatibant Peptide Fragment [Des-Gly5]
Arg-Pro-Hyp-Gly-Thi-Ser-D-Tic-Oic-Arg-OH
Icatibant Impurity 2
L-Arg(1)-Icatibant
Icatibant Impurity 3
(1-6)-Icatibant
(7-10)-Icatibant
Icatibant Impurity 4
Des-L-Arg(2)-Icatibant
Des-D-Arg(1)-Icatibant
Ac-Icatibant
N-Nitroso Icatibant Impurity 1
N-Nitroso Icatibant Impurity 2
N-Nitroso Icatibant Impurity 3
N-Nitroso Icatibant Impurity 4
N-Nitroso Icatibant Impurity 5
N-Nitroso Icatibant Impurity 6
N-Nitroso Icatibant Impurity 7
N-Nitroso Icatibant Impurity 8
N-Nitroso Icatibant Impurity 9
N-Nitroso Icatibant Impurity 10
N-Nitroso Icatibant Impurity 11
N-Nitroso Icatibant Impurity 12
Icatibant Impurity 1
Icatibant Impurity 5
D-Ser (7) Icatibant Trifluoroacetic acid

Metabolites

Endo-Gly:H-D-Arg-Arg-Pro-Hyp-Gly-Gly-Thi-Ser-D
ICA-(6-10) : H-Thi-Ser-D-Tic-Oic-Arg-OH

Isotope Labelled Compounds

N-Nitroso Tadalafil D3